Target intelligence / Profile preview

Clathrin light chain A (CLTA)

Target
CLTA
Molecular classification
Other (Vesicle coat protein subunit)
01

Overview

Clathrin light chain A (CLTA) is a key regulatory subunit of the clathrin coat complex, which forms clathrin-coated pits and vesicles responsible for receptor-mediated endocytosis and intracellular trafficking. Clathrin lattices are built from triskelions, each comprising three clathrin heavy chains and three light chains (including CLTA). While heavy chains provide structural support, CLTA regulates assembly and disassembly of the clathrin lattice, influencing vesicle formation, rigidity, and selectivity. CLTA interacts with actin-binding proteins (Hip1/Hip1R) and myosin VI, linking endocytic machinery to the cytoskeleton and facilitating vesicle budding especially under conditions of high membrane tension or in polarized cells. CLTA’s role is critical for proper internalization of cargo, including nutrients and signaling receptors, and it is co-opted by several pathogens for cell entry. However, CLTA itself is not currently considered a direct therapeutic target—the functional consequences of its perturbation are primarily of interest in basic research and cell biology.

Other names
CLTALcaLCAClathrin, light polypeptide (Lca)clathrin light chain A
02

Biological functions

EndocytosisMembrane traffickingReceptor internalizationOrganelle biogenesisRegulation of clathrin lattice assembly/disassemblyActin cytoskeleton coordinationCell signaling modulation
03

Disease associations

Infection (entry of bacteria/viruses)Neurodegenerative disease (implied via trafficking/synaptic vesicle function)Cancer (potential association with altered trafficking; direct evidence limited)

Beyond the preview

Go deeper on Clathrin light chain A (CLTA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clathrin light chain A (CLTA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call